The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
The TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) clinical trial will enroll up to 335 people in 47 sites in the U.S. Coronary Artery Disease (CAD) is the most common ...
Johnson & Johnson MedTech’s Shockwave Medical is launching a new intravascular lithotripsy catheter in ... J&J said Javelin demonstrated a procedure success rate of 99%, with a major ...